Japanese Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation [J-POPS]
N/A
N/A
Male
Prostate Cancer
Trial Information
Japanese Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation [J-POPS]
OBJECTIVES:
- To determine the efficacy of permanent brachytherapy with iodine I 125 seeds in
patients with localized prostate cancer.
- To determine the safety of this therapy in these patients.
OUTLINE: This is a multicenter study.
Patients undergo permanent brachytherapy seed implantation comprised of iodine I 125 into
the prostate. Some patients may receive combination treatment (e.g., external beam radiation
therapy (EBRT) or hormone therapy in addition to brachytherapy).
Quality of life and the International Prostate Symptom Score (IPSS) is assessed and
compared.
Inclusion Criteria
DISEASE CHARACTERISTICS:
- Clinically and histologically confirmed localized prostate cancer
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- No prior or concurrent surgery
- No prior or concurrent radiotherapy
- Prior chemotherapy, hormonal therapy, and biologic therapy allowed
Type of Study:
Interventional
Study Design:
Primary Purpose: Treatment
Outcome Measure:
PSA relapse-free survival
Safety Issue:
No
Principal Investigator
Hidetoshi Yamanaka, MD, PhD
Investigator Role:
Study Chair
Investigator Affiliation:
Translational Research Informatics Center, Kobe, Hyogo, Japan
Authority:
United States: Federal Government
Study ID:
CDR0000562726
NCT ID:
NCT00534196
Start Date:
July 2005
Completion Date:
Related Keywords:
- Prostate Cancer
- recurrent prostate cancer
- stage I prostate cancer
- stage IIB prostate cancer
- stage IIA prostate cancer
- stage III prostate cancer
- Prostatic Neoplasms
Name | Location |
|---|
